Kaushal Mohit
SEC CIK 1683021 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | Dir | 205.7K | — | $393.0K | 13 | 2021-11-12 | 2026-07-27 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-29 18:56 | 2026-07-27 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +33.1K | 205.7K | +19% | $0 | |
| MT | 2026-04-16 19:27 | 2026-04-14+ | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | S - Sale | $3.50 | -95.7K | 172.6K | -36% | -$335.1K |
| M | 2025-11-24 | 2025-11-20 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +91.0K | 228.2K | +66% | $0 |
| 2024-11-25 | 2024-11-22 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +56.0K | 177.3K | +46% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +53.3K | 121.3K | +79% | $0 | |
| 2023-03-21 | 2023-03-17 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +19.7K | 42.4K | +87% | $0 | |
| 2022-11-21 | 2022-11-17 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +22.7K | 48.2K | +89% | $0 | |
| 2022-11-15 | 2022-11-14 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | S - Sale | $2.13 | -16.0K | 25.5K | -39% | -$34.1K | |
| 2022-10-25 | 2022-10-24 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | S - Sale | $4.96 | -4,798 | 41.5K | -10% | -$23.8K | |
| M | 2022-03-23 | 2022-03-21 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | A - Grant | $0.00 | +20.8K | 41.5K | +100% | $0 |
| DA | 2021-11-18 | 2021-11-12 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| D | 2021-11-16 | 2021-11-12 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | C - Cnv Deriv | — | +30.0K | 30.0K | New | — |
| D | 2021-11-16 | 2021-11-12 | STLN | Starling Oncology, Inc. | Kaushal Mohit | Dir | D - Sale to Iss | — | -4,466 | 25.5K | -15% | — |
Purchase Sale Sale after option exercise All abbreviations